Purchase Order 75N93023P00602
Award Date 5/11/23
Potential Completion Date 5/10/24
Potential Value $1.9M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Illumina, Inc. was awarded a $898,275 firm fixed-price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide an Illumina NovaSeq 6000 sequencing system. The contract is in support of the Department of Health and Human Services' efforts responding to the Coronavirus Disease 2019 pandemic and will run from September 2021 through September 2022. Performance will take place in San Diego, California. No set-aside designation or...
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $906,270 purchase order to Illumina, Inc. to supply and install a NovaSeq 6000 sequencing system. The place of performance is in Bethesda, Maryland. The firm fixed price contract has a period of performance starting on July 7, 2020 and ending on August 31, 2020. The National Institutes of Health will utilize the new sequencing system in support of its biomedical...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $207,415 firm fixed price purchase order to Illumina, Inc. of San Diego, California. Under the terms of the contract, Illumina will provide one NEXTSEQ 2000 sequencing system to support NIH's research efforts in the areas of allergy and infectious disease. Place of performance is Illumina's facilities in San Diego. The period of performance is from...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 Sequencing System or equal, valued at $239,700.00. The requirement was issued through a commercial items solicitation using Simplified Acquisition Procedures, with no set-aside designation. The sequencing system is intended to support the increased workload at the Center for Human Immunology,...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $953,700.00 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer, to provide a NOVASEQ 6000 sequencing system. The contract has no set-aside designation and was completed on September 29, 2017. Illumina has previously received prime contracts from various federal agencies, including the NIH, CDC, USDA, and VA, to supply...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the U.S. Department of Health and Human Services, awarded a $999,999.00 firm fixed price purchase order to Illumina, Inc. to provide a NovaSeq X Plus sequencing system. This award is based on a September 2023 solicitation from the National Heart Lung and Blood Institute seeking a high-throughput DNA sequencing platform to support genomic research. The contract has no set-aside designation and a...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The $101,340.96 contract provides a one-year service plan for Illumina's NextSeq and MiSeq sequencing platforms, as well as an iSeq 100 system, to be used at an NIAID facility in Frederick, Maryland. The contract was...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,413 delivery order to Illumina, Inc. under an unspecified contract vehicle. The delivery order is for the ILLUMINA NOVASEQ X SERIES 10B REAGENT KIT (100 CYCLE) to support the agency's research efforts. Performance will occur in San Diego, California over a period of four years from September 2020 through February 2024. The contract has a firm fixed price...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $213,150 firm fixed price purchase order to Illumina, Inc. to deliver a NextSeq 1000 Sequencing System. The award was made under simplified acquisition procedures solicitation number RFQ-NIH-NIAID-2183146, which sought quotes for the sequencing system as well as its delivery to NIH in Bethesda, Maryland, installation, setup, operator training, and maintenance/support services. The...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. to provide an Illumina NextSeq 550 sequencing system. The potential value of the contract is $273,655.08. There was no set-aside designation for this award. Illumina, a for-profit manufacturer of genetic and genomic analysis instruments and reagents, has provided a range of sequencing systems and related...